Delivery Order SPE2DB22D9112-SPE2DB24FE6QS

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The delivery order is for the pharmaceutical product XOLAIR 150 MG/ML SYRINGE and has a firm fixed price of $6,189.60. The period of performance runs through February 13, 2024. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of pharmaceutical and medical supplies to...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler. The order, valued at $17,795.10, is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The delivery order is under a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of pharmaceutical items and medical supplies to support military...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of Xolair 150 mg/mL syringes, with a potential value of $37,137.60 and a completion date of January 12, 2024. The delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA, valued up to $5 million through December 2025, to provide a variety of pharmaceutical items...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is to provide the pharmaceutical product XOLAIR 150 MG/ML SYRINGE with a potential value of $3,094.80 and a completion date of February 9, 2024. This delivery order is issued against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA to provide various pharmaceutical and medical supplies...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,189.60, is for the delivery of XOLAIR 150 MG/ML syringes to support the medical supply needs of the Department of Defense. The order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which enables the agency to issue...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, with a completion date of March 13, 2024 and a potential value of $6,189.60. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the...

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML and has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that enables DLA to procure a broad range of pharmaceutical products and medical supplies to...

This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The delivery order, valued at $3,094.80, is for the supply of XOLAIR 150 MG/ML syringes. This delivery order is likely part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide various pharmaceutical and medical supplies to support military treatment facilities worldwide. The...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is valued at $3,094.80 and has a completion date of March 7, 2024. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. This order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, valued up to...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $7,737.00 and has an ultimate completion date of July 9, 2024. The contract is for the delivery of Xolair 150 mg/ml syringes, a specialty pharmaceutical product used to treat certain respiratory conditions. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC)...